Conventional cholesterol testing has historically been used as the standard indicator for cardiovascular disease, often being classified as “good” HDL or “bad” LDL. Studies have indicated that it is actually the lipoprotein particles that are responsible for key steps in plaque formation and the development of cardiovascular disease. The small, dense, cholesterol-depleted particles cause the highest risk, as well as a higher number of these lipoproteins. Measuring cholesterol alone is inadequate to assess with any accuracy an individual’s cardiovascular risk.
Lipoprotein Particle Profile is an advanced technology that measures both lipoprotein particle density and number with precision. This information can indicate cardiovascular abnormalities and inflammation, which is routinely missed using only a standard lipid panel, as well as evaluate early stages of cardiovascular disease.
This test involves a blood draw at our clinic, whereby we mail the vials of blood to a specialized lab for sophisticated evaluation.